This letter discusses therapeutic disparities between developing countries and developed countries for patients with nephropathic cystinosis, one of a number of rare diseases for which therapy exists but is unevenly distributed.
No takes yet. Share an insight, caveat, or question.
Bertholet‐Thomas et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: